Home // News & Events // Press Releases // Press Release
DALLAS – NOVEMBER 20, 2013 – A new KLAS report, Population Health Management 2013: Scouting the PHM Roster, released this month, ranks Phytel as an “early leader” in the fast-evolving market for population health management (PHM) solutions.
Phytel was one of only two companies profiled in the KLAS report to earn the top rating of “early leader” in both portfolio breadth and PHM experience. According to the report, Phytel is one of only a handful of companies to stand out from the pack by providing an end-to-end solution portfolio and deep experience in population health management including a significant customer base of large health systems, integrated delivery networks (IDNs), and multi-specialty physician groups.
Figure 1. © 2013 KLAS Enterprises, LLC. All rights reserved. www.KLASresearch.com.
“Managing the health of populations is a critical skillset for healthcare delivery organizations looking to shift from fee-for-service reimbursement to value-based care,” said Steve Schelhammer, CEO of Phytel. “We are excited that KLAS has identified us as an early leader in this space. It is a testament to our spirit of innovation and to our clients, who have embraced the changes underway and determined that the path forward lies through Phytel.”
The KLAS report states that the market shift towards value-based care has created a mix of companies claiming to provide a full-spectrum population health management solution, but that some early leaders are emerging based on their portfolio breadth, experience, and ability to deliver. The report indicates that Phytel delivers the key elements of the full spectrum of PHM capabilities, including data aggregation, risk stratification, care coordination and patient engagement. The report also highlights Phytel for its “historical lead” in patient outreach, the “least offered” capability among the PHM vendors.
The report noted the recent strategic alliance between Phytel and Verisk Health, another company reviewed in the report. Phytel and Verisk Health, a subsidiary of Verisk Analytics (Nasdaq:VRSK), believe their business relationship provides clients of both companies with an integrated solution combining claims-based risk assessment and medical cost management with enterprise-level care management.
The report, Population Health Management 2013: Scouting the PHM Roster, is available at klasresearch.com/reports.
About Phytel The premier company empowering physician-led population health improvement, Phytel provides physicians with proven technology to deliver timely, coordinated care to their patients. Phytel's state-of-the-art registry, which now encompasses more than 30 million patients nationwide, uses evidence-based chronic and preventive care protocols to identify and notify patients due for service, while tracking compliance and measuring quality and financial results. Phytel is ISO 9001:2008 certified, confirming adherence to ISO's internationally recognized Total Quality Management (TQM) standards. For more information, please visit www.phytel.com. Follow us on Twitter and find us on Facebook.
Amendola Communications for Phytel
11511 Luna Road, Suite 600
Dallas, TX 75234
800.559.3057 - Toll Free